Expressive Writing on Stress-Related and Work-Related Outcomes Among Chinese Nursing Interns

March 21, 2026 updated by: JI XUAN, Changzhi Medical College

Effects of Expressive Writing on Stress-Related and Work-Related Outcomes Among Chinese Nursing Interns: a Randomized Controlled Trial

The goal of this interventional study is to assess the effects of an intervention on stress-related and work-related outcomes among Chinese nursing interns. The main questions it aims to answer are:

  • Does expressive writing reduce clinical practice stress and improve coping strategies in nursing interns?
  • Does expressive writing increase work engagement and perceived professional benefit among nursing interns?

Participants in the intervention group and control group will perform expressive writing and neutral writing, respectively, based on different given instructions. In both groups, writing will last for 10-15 minutes each time, twice a week, for nine weeks.

Researchers will compare the outcomes of the two groups to see if there are differences between clinical practice stress, coping strategies, work engagement, and perceived professional benefit.

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

52

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Shanxi
      • Changzhi, Shanxi, China
        • Changzhi Medical College

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Undergraduate nursing interns in their first clinical internship (had no prior clinical practice experience)
  • Be willing to fill in questionnaires and write according to the assigned writing prompts
  • Never participated in writing therapy or stress management intervention programs

Exclusion Criteria:

  • Refusal to participate
  • Severe current psychological conditions
  • Undergoing any form of psychotherapy
  • With a habit of keeping diaries

Withdrawal criteria:

  • Termination of internship for whatever reason
  • Not submit writing materials twice

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: intervention group

According to the writing prompts, online expressive writing focuses on stressful events and will be conducted twice a week (every Monday and Thursday) for 10-15 minutes each time, lasting for nine weeks.

Writing prompts are developed based on Emotional Processing Theory (EPT) and Cognitive Adaptation Theory (CAT).

Sham Comparator: control group
According to the writing prompts, online neutral writing focuses on immediate surroundings and will be conducted twice a week (every Monday and Thursday) for 15 minutes each time, lasting for ten weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean Change from Baseline in Clinical Practice Stress Scores on the Stress Rating Scale for Nursing Interns in Practice at 9 Weeks, 11 Weeks and 13 Weeks
Time Frame: At baseline, post-intervention at Week 9, 11-week and 13-week follow-ups.
The scale consists of 6 dimensions and 37 entries, including the nature of work, workload, preparation for an internship, interpersonal relationships, work support, and learning and work impulse. The scale rates on a 4-point Likert scale, with no stress, mild stress, moderate stress, and severe stress, assigned a score of 0, 1, 2, and 3, respectively, and the higher the score, the greater the stress.
At baseline, post-intervention at Week 9, 11-week and 13-week follow-ups.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean Change from Baseline in Positive and Negative Coping Style Scores on the Brief Coping Style Scale at 9 Weeks, 11 Weeks and 13 Weeks
Time Frame: At baseline, post-intervention at Week 9, 11-week and 13-week follow-ups.
The scale consists of two dimensions, positive and negative coping, with 20 entries. A 4-point Likert scale is used, with 1-4 indicating "not used" to "often used". Positive coping has 12 entries, and negative coping has 8 entries, with higher scores indicating more frequent use of coping strategies.
At baseline, post-intervention at Week 9, 11-week and 13-week follow-ups.
Mean Change from Baseline in Work Engagement Scores on the Utrecht Work Engagement Scale at 9 Weeks, 11 Weeks and 13 Weeks
Time Frame: At baseline, post-intervention at Week 9, 11-week and 13-week follow-ups.
The scale consists of 3 dimensions: vitality, dedication, and concentration, comprising 15 entries. A 7-point Likert scale is used, with scores ranging from 0-6 for "never," "almost never," "rarely," "sometimes," "often," "frequently," and "always." The total score is the sum of the scores of each entry. An average entry score of 4 or more is defined as a high level of work engagement, 2-4 as a moderate level, and less than 2 as a low level of work engagement.
At baseline, post-intervention at Week 9, 11-week and 13-week follow-ups.
Mean Change from Baseline in Perceived Professional Benefits Scores on the Perceived Professional Benefits Scale at 9 Weeks, 11 Weeks and 13 Weeks
Time Frame: At baseline, post-intervention at Week 9, 11-week and 13-week follow-ups.
The scale consists of 7 items of positive career sense, 6 items of good nurse-patient relationship, 6 items of sense of belonging to the team, 8 items of self-growth, and 6 items of identification with friends and relatives, totaling 33 items in 5 dimensions, and each item is scored 1 to 5 on a 5-point Likert scale ranging from "strongly disagree" to "strongly agree. The higher the score, the stronger the perceived professional benefit.
At baseline, post-intervention at Week 9, 11-week and 13-week follow-ups.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: XUAN JI, Changzhi Medical College

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 15, 2024

Primary Completion (Actual)

October 13, 2024

Study Completion (Actual)

October 13, 2024

Study Registration Dates

First Submitted

January 24, 2024

First Submitted That Met QC Criteria

January 31, 2024

First Posted (Actual)

February 2, 2024

Study Record Updates

Last Update Posted (Actual)

March 25, 2026

Last Update Submitted That Met QC Criteria

March 21, 2026

Last Verified

September 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • RT2023047

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Individual deidentified participant data underlying the results reported in this article, including demographic information and outcome measures, will be shared.

IPD Sharing Time Frame

The data will be available beginning one month after manuscript acceptance and will remain accessible for three years thereafter.

IPD Sharing Access Criteria

The data will be shared with researchers who submit a methodologically sound research proposal for non-commercial academic purposes. Requests should be submitted to the corresponding author, and approved requestors will be required to sign a data use agreement prior to data access.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stress, Psychological

Clinical Trials on Neutral writing

Subscribe